Total Funding
68
57
Total FundingPost-IPO Equity raised
Growth Score
-17 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
71660
Biodexa Pharmaceuticals is a pharmaceutical company focused on particle engineering with an emphasis on microfluidics and drug delivery.
- Dmitry Zamoryakhin: Chief Scientific Officer
- Fiona Sharp: Chief Financial Officer and Company SecretaryPast Role: Biodexa Pharmaceuticals, Group Financial Controller
About the Company
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a commercial platform and four marketed products in the US. Midatech's strategy is to develop products in-house in oncology and with partners in other indications, and to accelerate growth organically and through
strategic acquisitions.
